LeMaitre Vascular grows sales 10% in Q1 results

Lemaitre Vascular (NSDQ:LMAT) posted first-quarter results that beat the revenue consensus on Wall Street and missed earnings estimates.

The Burlington, Massachusetts-based vascular device company reported profits of $6 million, or 27¢ per share on sales of $39.6 million for the three months ended March 31, for a bottom-line gain of 1.8% on sales growth of 10.25% compared with Q1 2021.

Get the full story on our sister site, Medical Tubing + Extrusion.

Read more
  • 0

LeMaitre Vascular beats The Street in Q4, grows sales 5%

LeMaitre Vascular (NSDQ:LMAT) this week posted fourth-quarter results that beat the overall consensus forecast on Wall Street.

The Burlington, Massachusetts-based company reported profits of $6.2 million, or 28¢ per share, on sales of $39.5 million for the three months ended Dec. 31, 2021, for a bottom-line loss of -12.2% on sales growth of 5.21% compared with Q4 2020.

Get the full story on our sister site, Medical Tubing + Extrusion.

Read more
  • 0

LeMaitre profits up 86% in Q1 results

LeMaitre Vascular (NSDQ:LMAT) posted first-quarter results yesterday that beat the consensus on Wall Street.

The company reported profits of $5.9 million, or 28¢ per share, on sales of $35.8 million, for the three months ended March 31, for a bottom-line gain of 86.8% sales growth of 17.45% compared with Q1 2020.

Earnings per share were 28¢∞, 1¢ ahead of The Street, where analysts were looking for sales of $35.2 million.

“Double-digit sales growth and restrained expenses enabled 83% bottom-line growth. And our 22% op. margin enabled us to improve the balance sheet,” CEO George LeMaitre said in a news release.

LeMaitre did not provide a financial outlook for the remainder of the fiscal year.

Shares in LMAT were down -0.2% to $53.86 apiece at a market close yesterday and were at a standstill this morning.

Read more
  • 0

The worst catheter-based device recalls of 2020

Top: Teleflex Langston Dual Lumen catheter; Bottom: BSX Imager II, Endologix Ovation iX, Teleflex AC3 Optimus Intra-Aortic balloon pump

The U.S. saw nine serious medical device recalls related to catheters in 2020 — up from four the previous year, according to the FDA.

FDA in 2020 reported a total 33 medical device recalls at its most serious Class I level, down from 49 in 2019.

The list of the most serious catheter-based device recalls in 2020 includes products from major companies including Medtronic and Teleflex, and catheters ranging from congenital heart treatment devices to contrast material delivery devices.

Here are the nine most serious catheter-based device recalls of 2020.

Next >>
Read more
  • 0

The worst catheter-based device recalls of 2020

Top: Teleflex Langston Dual Lumen catheter; Bottom: BSX Imager II, Endologix Ovation iX, Teleflex AC3 Optimus Intra-Aortic balloon pump

The U.S. saw nine serious medical device recalls related to catheters in 2020 — up from four the previous year, according to the FDA.

FDA in 2020 reported a total 33 medical device recalls at its most serious Class I level, down from 49 in 2019.

The list of the most serious catheter-based device recalls in 2020 includes products from major companies including Medtronic and Teleflex, and catheters ranging from congenital heart treatment devices to contrast material delivery devices.

Here are the nine most serious catheter-based device recalls of 2020.

Next >>
Read more
  • 0